ANI Pharmaceuticals Stock Forecast
ANI Pharmaceuticals stock downgraded from Hold/Accumulate to Sell Candidate after Tuesday trading session.
(Updated on May 07, 2024)
The ANI Pharmaceuticals stock price fell by -0.95% on the last day (Tuesday, 7th May 2024) from $67.36 to $66.72. During the last trading day the stock fluctuated 1.56% from a day low at $66.70 to a day high of $67.74. The price has risen in 7 of the last 10 days and is up by 0.88% over the past 2 weeks. Volume has increased on the last day by 32 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 148 thousand shares were bought and sold for approximately $9.88 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.54% during the next 3 months and, with a 90% probability hold a price between $71.96 and $83.71 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ANIP Signals & Forecast
There are mixed signals in the stock today. The ANI Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $67.09. On a fall, the stock will find some support from the short-term average at $66.64. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -4.26%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for ANI Pharmaceuticals stock
ANI Pharmaceuticals finds support from accumulated volume at $66.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $1.04 between high and low, or 1.56%. For the last week the stock has had daily average volatility of 1.70%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ANIP) For The Upcoming Trading Day Of Wednesday 8th
For the upcoming trading day on Wednesday, 8th we expect ANI Pharmaceuticals to open at $67.05, and during the day (based on 14 day Average True Range), to move between $65.44 and $68.00, which gives a possible trading interval of +/-$1.28 (+/-1.92%) up or down from last closing price. If ANI Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.84% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $66.13 (0.88%) than the resistance at $67.67 (1.42%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
ANI Pharmaceuticals will release earnings BMO on Friday, May 10, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.98. We will update the financials statements for ANI Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 14.40% in the first trading day after earnings release.
Is ANI Pharmaceuticals stock A Buy?
ANI Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -4.161 Sell Candidate Downgraded
Predicted Opening Price for ANI Pharmaceuticals of Wednesday, May 8, 2024
Fair opening price May 8, 2024 | Current price |
---|---|
$67.05 ( 0.500%) | $66.72 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ANIP
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 68.09 | 2.06 % | |
R2 | 67.70 | 1.46 % | ||
R1 | 67.45 | 1.09 % | ||
Current price: | 66.72 | |||
Support | S1 | 66.66 | -0.0958 % | |
S2 | 66.41 | -0.464 % | ||
S3 | 66.01 | -1.06 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 69.13 | 3.61 % | |
R2 | 67.87 | 1.72 % | ||
R1 | 67.67 | 1.42 % | ||
Current price | 66.72 | |||
Support | S1 | 66.13 | -0.88% | |
S2 | 66.00 | -1.08% | ||
S3 | 65.48 | -1.86% |
FAQ
Click here for our free guide on how to buy ANI Pharmaceuticals Stock.